Abbara A, et al. Drug-Induced Liver Injury from Antituberculous Treatment: A
Retrospective From A Large TB Centre in the UK. 2017. Biomed Central Research Article. London. Vol 17 p1-12 Chalasani NP, Hayasgi PH, Bonkovski HI, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950-66. Chen M, et al. Drug-Induced Liver Injury: Interactions Between Drug Properties and Host Factors. 2015. Journal of Hepatology Elsevier. Germany. vol 63 p503-14 Chughlay MF, et al. A Clinical Approach to Drug-Induced Injury. 2015. Current Allergy and Clinical Immunology. Cape Town. vol;28 p252-6 Dolores B. Drug-Induced Hepatotoxicity: Metaboic, Genetic, and Immunological Basis. 2014. Int J Mol SCI. United States. vol 15 p6990-7001 Fisher K, et al. Drug Induced Liver Injury. 2015. Arch Pathol Lab Med. vol 139 p876- 85 Jong E, Conradie F, Berhanu R, Black A, John MA, Meintjes G, Menezes C. Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB. S Afr J HIV Med. 2013;14(3):113-9. Jussi J, et al. An Official ATS Statement: Hepatotoxicity Of Antituberculosis Therapy. 2006. Am J Respiratory Critical Care Med. United States. vol 174 p935-48 Kemenkes RI. Riset Kesehatan Dasar (RISKESDAS) 2010. Jakarta : Kemenkes RI; Kullack U, et al. Drug-induced Liver Injury: Recent Advances in Diagnosis and Risk Assessment. 2017. BMJ Publishing Group. Switzerland. p1-13 Loho IM, Hasan I. Drug induced liver injury- tantangan dalam diagnosis. CDK.2010.2014;41(3):167-70 Maria IL, Hasan I. Drug-Induced Liver Injury- Tantangan dalam Diagnosis. 2014. CDK Fakultas Kedokteran Universitas Indonesia. Jakarta. vol 41 p167-70 Tendean M. Hepatitis Imbas Obat. 2014. Departemen Ilmu Penyakit Dalam Universitas Kristen Krida Wacana. Jakarta. p1-20 Triya N, et al. Tatalaksana Pasien Tuberculosis, Chap 3. Pedoman Nasional P-TB. 2014. p22-37